SNTI icon

Senti Biosciences
SNTI

Overview Fund Activity

28 hedge funds and large institutions have $7.64M invested in Senti Biosciences in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 2 closing their positions.

Holders
28
Holders Change
+4
Holders Change %
+16.67%
% of All Funds
0.44%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
6
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
TM
1
Triatomic Management
California
$188K
2
BCM
2
Bridgeway Capital Management
Texas
$90.4K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$347K
4
VF
4
Virtu Financial
New York
$22K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$11K

Top Sellers

1
NMC
1
NEA Management Company
Maryland
$2.78M
2
Morgan Stanley
2
Morgan Stanley
New York
$10.7K
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$2.12M
4
AIM
4
ARK Investment Management
Florida
$1.15M
5
Citigroup
5
Citigroup
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
WAM
26
Wolverine Asset Management
Illinois
$501 800 – –
Bank of America
27
Bank of America
North Carolina
$133 212 +212 New
Wells Fargo
28
Wells Fargo
California
$88 140 +7 +5%
Citigroup
29
Citigroup
New York
– – -14,472 Closed
UBS Group
30
UBS Group
Switzerland
– – -5,398 Closed
CFGS
31
Concourse Financial Group Securities
Alabama
– – – –
1
2